Martinez-Taboada Fernando, Leece Elizabeth A
The Queen's Veterinary School Hospital, University of Cambridge, Cambridge, UK.
Vet Anaesth Analg. 2014 Nov;41(6):575-82. doi: 10.1111/vaa.12171. Epub 2014 May 29.
To compare anaesthetic induction in healthy dogs using propofol or ketofol (a propofol-ketamine mixture).
Prospective, randomized, controlled, 'blinded' study.
Seventy healthy dogs (33 males and 37 females), aged 6-157 months and weighing 4-48 kg.
Following premedication, either propofol (10 mg mL(-1)) or ketofol (9 mg propofol and 9 mg ketamine mL(-1)) was titrated intravenously until laryngoscopy and tracheal intubation were possible. Pulse rate (PR), respiratory rate (f(R)) and arterial blood pressure (ABP) were compared to post-premedication values and time to first breath (TTFB) recorded. Sedation quality, tracheal intubation and anaesthetic induction were scored by an observer who was unaware of treatment group. Mann-Whitney or t-tests were performed and significance set at p ≤ 0.05.
Induction mixture volume (mean ± SD) was lower for ketofol (0.2 ± 0.1 mL kg(-1)) than propofol (0.4 ± 0.1 mL kg(-1)) (p < 0.001). PR increased following ketofol (by 35 ± 20 beats minute(-1)) but not consistently following propofol (4 ± 16 beats minute(-1)) (p < 0.001). Ketofol administration was associated with a higher mean arterial blood pressure (MAP) (82 ± 10 mmHg) than propofol (77 ± 11) (p = 0.05). TTFB was similar, but ketofol use resulted in a greater decrease in f(R) (median (range): ketofol -32 (-158 to 0) propofol -24 (-187 to 2) breaths minute(-1)) (p < 0.001). Sedation was similar between groups. Tracheal intubation and induction qualities were better with ketofol than propofol (p = 0.04 and 0.02 respectively).
Induction of anaesthesia with ketofol resulted in higher PR and MAP than when propofol was used, but lower f(R). Quality of induction and tracheal intubation were consistently good with ketofol, but more variable when using propofol.
比较使用丙泊酚或氯胺酮丙泊酚合剂(一种丙泊酚与氯胺酮的混合物)对健康犬进行麻醉诱导的效果。
前瞻性、随机、对照、“盲法”研究。
70只健康犬(33只雄性和37只雌性),年龄6 - 157个月,体重4 - 48千克。
给予术前用药后,静脉滴定丙泊酚(10毫克/毫升)或氯胺酮丙泊酚合剂(9毫克丙泊酚和9毫克氯胺酮/毫升),直至能够进行喉镜检查和气管插管。将心率(PR)、呼吸频率(f(R))和动脉血压(ABP)与术前用药后的数值进行比较,并记录首次呼吸时间(TTFB)。由一名不知道治疗组情况的观察者对镇静质量、气管插管和麻醉诱导进行评分。进行曼 - 惠特尼检验或t检验,显著性设定为p≤0.05。
氯胺酮丙泊酚合剂的诱导混合液体积(均值±标准差)低于丙泊酚(0.2±0.1毫升/千克对0.4±0.1毫升/千克)(p < 0.001)。氯胺酮丙泊酚合剂给药后PR升高(升高35±20次/分钟),而丙泊酚给药后PR升高不具有一致性(升高4±16次/分钟)(p < 0.001)。使用氯胺酮丙泊酚合剂时平均动脉压(MAP)较高(82±10毫米汞柱),高于丙泊酚(77±11毫米汞柱)(p = 0.05)。TTFB相似,但使用氯胺酮丙泊酚合剂导致f(R)下降幅度更大(中位数(范围):氯胺酮丙泊酚合剂 - 32(- 158至0),丙泊酚 - 24(- 187至2)次/分钟)(p < 0.001)。两组之间的镇静效果相似。氯胺酮丙泊酚合剂在气管插管和诱导质量方面优于丙泊酚(分别为p = 0.04和0.02)。
与使用丙泊酚相比,使用氯胺酮丙泊酚合剂进行麻醉诱导时PR和MAP较高,但f(R)较低。氯胺酮丙泊酚合剂诱导和气管插管的质量始终良好,而使用丙泊酚时则更具变异性。